Pre-introductory clinical trials of Norplant implants: a comparison of seventeen countries' experience
- PMID: 8585885
- DOI: 10.1016/0010-7824(00)10782-n
Pre-introductory clinical trials of Norplant implants: a comparison of seventeen countries' experience
Abstract
This report summarizes the data collected in pre-introductory Norplant implants clinical trials in 17 countries in Latin America, Asia and Africa that were coordinated by either the Population Council or Family Health International (FHI) between 1984 and 1991. A total of 16,282 women between the ages of 18 and 40 years participated in the studies with semi-annual or annual follow-up visits for up to 5 years. Gross cumulative pregnancy rates were < 0.6 per 100 women in the first year and < 1.5 in the second year in all countries. Significant differences in cumulative 5-year pregnancy rates were observed between weight groups 40-49 and 50-59 kg and between 50-59 and 60-69 kg body weight but not between 60-69 kg and those > or = 70 kg. Total cumulative discontinuation rates after five years of Norplant implants use ranged from 35.8 to 60.0 per 100 women. Younger age and low parity were associated with a higher discontinuation rate. Cumulative discontinuation rates for menstrual reasons more than doubled between the end of the first year and second year of use in 13 of 17 countries. This analysis and one previous review provide the only comparison of Norplant contraceptive system study results across a wide diversity of countries; thus allowing an appreciation of the range of clinical experience with Norplant implants and the regional differences in that experience.
Similar articles
-
Effectiveness of Norplant implants among Thai women in Bangkok.Contraception. 1996 Jan;53(1):33-6. doi: 10.1016/0010-7824(95)00261-8. Contraception. 1996. PMID: 8631187 Clinical Trial.
-
The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study.Hum Reprod. 1998 Dec;13(12):3371-8. doi: 10.1093/humrep/13.12.3371. Hum Reprod. 1998. PMID: 9886517 Clinical Trial.
-
Efficacy and continuation rates of Norplant in Pakistan.Contraception. 1999 Jul;60(1):39-43. doi: 10.1016/s0010-7824(99)00054-2. Contraception. 1999. PMID: 10549451
-
Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.Drug Saf. 2003;26(5):303-35. doi: 10.2165/00002018-200326050-00002. Drug Saf. 2003. PMID: 12650633 Review.
-
Hormonal implants: contraception for a new century.Am J Obstet Gynecol. 1994 May;170(5 Pt 2):1536-43. doi: 10.1016/s0002-9378(94)05016-7. Am J Obstet Gynecol. 1994. PMID: 8178903 Review.
Cited by
-
[Indication of a contraceptive method to a teenager: subcutaneous implant of gestagen].Aten Primaria. 2004 Nov 30;34(9):499-503. doi: 10.1016/s0212-6567(04)79537-2. Aten Primaria. 2004. PMID: 15563789 Free PMC article. Review. Spanish. No abstract available.
-
Hormonal contraceptives for contraception in overweight or obese women.Cochrane Database Syst Rev. 2016 Aug 18;2016(8):CD008452. doi: 10.1002/14651858.CD008452.pub4. Cochrane Database Syst Rev. 2016. PMID: 27537097 Free PMC article. Review.
-
Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability.Drugs. 1998 Jun;55(6):861-87. doi: 10.2165/00003495-199855060-00019. Drugs. 1998. PMID: 9617600 Review.
-
Contraceptive use by obese women 1 year postpartum.Contraception. 2009 Nov;80(5):463-8. doi: 10.1016/j.contraception.2009.03.017. Epub 2009 May 9. Contraception. 2009. PMID: 19835721 Free PMC article. Clinical Trial.
-
Levonorgestrel subdermal implants. Contraception on trial.Drug Saf. 1997 Dec;17(6):360-8. doi: 10.2165/00002018-199717060-00002. Drug Saf. 1997. PMID: 9429835 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources